TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 281 filers reported holding TANDEM DIABETES CARE INC in Q1 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,838,000 | -49.2% | 247,391 | -37.1% | 1.29% | -28.9% |
| Q2 2022 | $23,287,000 | +51.5% | 393,425 | +197.7% | 1.82% | +54.1% |
| Q1 2022 | $15,371,000 | -19.5% | 132,175 | +4.1% | 1.18% | -3.0% |
| Q4 2021 | $19,106,000 | +135.6% | 126,931 | +86.8% | 1.22% | +117.1% |
| Q3 2021 | $8,111,000 | -58.7% | 67,942 | -66.3% | 0.56% | -51.3% |
| Q2 2021 | $19,630,000 | +21.9% | 201,535 | +10.5% | 1.15% | +5.0% |
| Q1 2021 | $16,097,000 | -22.6% | 182,400 | -16.1% | 1.10% | -28.9% |
| Q4 2020 | $20,794,000 | +221.4% | 217,330 | +281.3% | 1.54% | +251.8% |
| Q3 2020 | $6,469,000 | -59.8% | 56,996 | -65.0% | 0.44% | -41.2% |
| Q2 2020 | $16,102,000 | +78.6% | 162,786 | +16.2% | 0.74% | -37.7% |
| Q1 2020 | $9,015,000 | – | 140,086 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |